DOSSIER · 13F Holders · Q2 2026Healthcare · Biological Products, (No Diagnostic Substances)
RGEN
REPLIGEN CORP
498 institutions still hold REPLIGEN CORP as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 759916109·Biological Products, (No Diagnostic Substances)·498 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
498 institutions reported RGEN in Q2 2026. BlackRock, Inc. leads at 13.8% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 25
478 more holders available. Log in →